Trans-sphenoidal surgery for microprolactinoma: An acceptable alternative to dopamine agonists?

European Journal of Endocrinology

Volumn 140, Issue 1, 1999, Pages 43-47

  Turner, Helen E ^a   Adams, Christopher B T ^a   Wass, John A H ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIABETES INSIPIDUS; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; FEMALE; FOLLOW UP; HORMONE DEFICIENCY; HUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RETROSPECTIVE STUDY; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; ERRATUM; ERROR;

ADOLESCENT; ADULT; DOPAMINE AGONISTS; DRUG RESISTANCE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RETROSPECTIVE STUDIES; SPHENOID BONE;

EID: 0033016190     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400043     Document Type: Article

References (20)

1. Thorner MO, McNeilly AS, Hagan C & Besser GM. Long-term treatment of galactorrhoea and hypogonadism wilh bromocriptine. British Medical Journal 1974 2 419-422.
2. Bevan JS, Webster J, Burke CW & Scanlon MF. Dopamine agonists and pituitary tumour shrinkage. Endocrine Reviews 1992 131 220-240.
3. Molitch ME. Pathologic hyperprolactinaemia. Endocrinology and Metabolism Clinics of North America 1992 21 877-901.
4. Webster J, Piscitelli G, Polli A, D'Alberton A, Falsetti L, Ferrari C et al. The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open uncontrolled, multicentre study. Clinical Edocrinology 1993 39 323-329.
5. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF for the Cabergoline Comparative Study Group. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhoea. New England Journal of Medicine 1994 331 904-909.
6. Ferrari C, Paracchi A, Mattei AM, de Vincentis S, D'Alberton A & Crosignani P. Cabergoline in the long-term therapy of hyperprolactinaemic disorders. Acta Endocrinologica 1992 126 489-494.
7. Colao A, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B et al. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. Journal of Clinical Endocrinology and Metabolism 1997 82 876-883.
8. Molitch M, Thorner MO & Wilson C. Management of prolactinomas. Therapeutic controversy. Journal of Clinical Endocrinology and Metabolism 1997 82 996-1000.
9. Serri O, Rasio E, Beauregard H, Hardy J & Somma M. Recurrence of hyperprolactinaemia after selective adenomectomy in women with prolactinoma. New England Journal of Medicine 1983 309 280-283.
10. Scanlon MF, Peters JR, Thomas JP, Richards SH, Morton WH, Howell S et al. Management of selected patients with hyperprolactinaemia by partial hypophysectomy. British Medical Journal 1985 291 1547-1550.
11. Thomson JA, Teasdale GM, Gordon D, McCruden DC & Davies DL. Treatment of presumed prolactinoma by trans-sphenoidal operation: early and late results. British Medical Journal 1985 291 1550-1553.
12. Rodman EF, Molitch ME, Kalmon PD, Biller BJ & Reichlin S. Long-term follow-up of trans-sphenoidal selective adenomectomy for prolactinoma. Journal of the American Medical Association 1984 252 921-924.
13. Scamoni C, Balzarini C, Crivelli G & Dorizzi A. Treatment and long-term follow-up results of prolactin secreting pituitary adenomas. Journal of Neurosurgical Sciences 1991 35 9-16.
14. Thomson JA, Davies DL, McClaren E & Teasdale GM. Ten year follow-up of microprolactinoma treated by trans-sphenoidal surgery. British Medical Journal 1994 309 1409-1410.
15. Serri O, Hardy J & Massoud F. Relapse of hyperprolactinaemia revisited. New England Journal of Medicine 1995 329 1357.
16. Soule SG, Farhi J, Conway GS, Jacobs HS & Powell M. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy. Clinical Endocrinology 1996 44 711-716.
17. Webster J, Page MD, Bevan JS, Richards SH, Douglas-Jones AG & Scanlon MF. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests. Clinical Endocrinology 1992 36 35-44.
18. Molitch ME & Russell EJ. The pituitary 'incidentaloma'. Annals of Internal Medicine 1990 112 925-931.
19. Hall WA, Luciano MG, Doppman JL, Patronas NJ & Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Annals of Internal Medicine 1994 120 817-820.
20. Jeffcoate WJ, Pund N, Sturrock NDC & Lambourne J. Long-term follow-up of patients with hyperprolactinaemia. Clinical Endocrinology 1996 45 299-303.